{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:29:31Z","timestamp":1793039371672,"version":"4.5.0"},"reference-count":435,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007743","name":"European Society for Clinical Nutrition and Metabolism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012355","name":"United European Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clnu.2023.03.021","type":"journal-article","created":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:10:02Z","timestamp":1681125002000},"page":"987-1024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Practical guideline on obesity care in patients with gastrointestinal and liver diseases \u2013 Joint ESPEN\/UEG guideline"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2614-5948","authenticated-orcid":false,"given":"Stephan C.","family":"Bischoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8795-5253","authenticated-orcid":false,"given":"Johann","family":"Ockenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0751-5712","authenticated-orcid":false,"given":"Ahad","family":"Eshraghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4049-2404","authenticated-orcid":false,"given":"Rocco","family":"Barazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-8980","authenticated-orcid":false,"given":"Luca","family":"Busetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8111-6026","authenticated-orcid":false,"given":"Marjo","family":"Campmans-Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-3341","authenticated-orcid":false,"given":"Vincenzo","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Chermesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-9256","authenticated-orcid":false,"given":"Haluk Tarik","family":"Kani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6444-7416","authenticated-orcid":false,"given":"Wafaa","family":"Khannoussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-0485","authenticated-orcid":false,"given":"Laurence","family":"Lacaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-0461","authenticated-orcid":false,"given":"Miguel","family":"L\u00e9on-Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8095-7707","authenticated-orcid":false,"given":"Juan M.","family":"Mendive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-357X","authenticated-orcid":false,"given":"Michael W.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6206-0226","authenticated-orcid":false,"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7238-1728","authenticated-orcid":false,"given":"Anders","family":"Thorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7153-4753","authenticated-orcid":false,"given":"Darija","family":"Vranesic Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-2171","authenticated-orcid":false,"given":"Arved","family":"Weimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7081-622X","authenticated-orcid":false,"given":"Cristina","family":"Cuerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2023.03.021_bib1","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.clnu.2022.07.003","article-title":"European guideline on obesity care in patients with gastrointestinal and liver diseases - joint ESPEN\/UEG guideline","volume":"41","author":"Bischoff","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/ueg2.12280","article-title":"European guideline on obesity care in patients with gastrointestinal and liver diseases - joint European Society for Clinical Nutrition and Metabolism\/United European Gastroenterology guideline","volume":"10","author":"Bischoff","year":"2022","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.clnu.2023.03.021_bib3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.clnu.2015.07.008","article-title":"Standard operating procedures for ESPEN guidelines and consensus papers","volume":"34","author":"Bischoff","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib4","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.clnu.2019.11.002","article-title":"ESPEN practical guideline: clinical Nutrition in inflammatory bowel disease","volume":"39","author":"Bischoff","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clnu.2016.12.027","article-title":"ESPEN guideline: clinical nutrition in inflammatory bowel disease","volume":"36","author":"Forbes","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20429","article-title":"Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients","volume":"14","author":"Nguyen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0148607114566656","article-title":"Self-screening for malnutrition risk in outpatient inflammatory bowel disease patients using the malnutrition universal screening tool (MUST)","volume":"40","author":"Sandhu","year":"2016","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10620-015-3895-2","article-title":"Analysis of hospital-based emergency department visits for inflammatory bowel disease in the USA","volume":"61","author":"Gajendran","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"Ananthakrishnan","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/DCR.0b013e3182698f60","article-title":"Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP","volume":"55","author":"Wallaert","year":"2012","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clnu.2023.03.021_bib11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/ajg.2010.105","article-title":"A\u00a0novel risk score to stratify severity of Crohn's disease hospitalizations","volume":"105","author":"Ananthakrishnan","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clnu.2018.12.022","article-title":"ESPEN guideline on clinical nutrition in liver disease","volume":"38","author":"Plauth","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.clnu.2020.01.004","article-title":"ESPEN guideline on clinical nutrition in acute and chronic pancreatitis","volume":"39","author":"Arvanitakis","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","article-title":"ESPEN guideline on clinical nutrition in the intensive care unit","volume":"38","author":"Singer","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.clnu.2017.02.013","article-title":"ESPEN guideline: clinical nutrition in surgery","volume":"36","author":"Weimann","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib17","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s10620-015-3629-5","article-title":"Obesity in inflammatory bowel disease: a marker of less severe disease","volume":"60","author":"Flores","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib18","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.crohns.2012.09.009","article-title":"High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors","volume":"7","author":"Nic Suibhne","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.advms.2015.07.004","article-title":"Overweight and obesity in children with newly diagnosed inflammatory bowel disease","volume":"61","author":"Pituch-Zdanowska","year":"2016","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib20","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/MIB.0000000000000560","article-title":"Impact of obesity on the management and clinical course of patients with inflammatory bowel disease","volume":"21","author":"Seminerio","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib21","first-page":"566","article-title":"Patients with inflammatory bowel disease have higher abdominal adiposity and less skeletal mass than healthy controls","volume":"31","author":"Barroso","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0148607189013005455","article-title":"Steroids and bowel rest versus elemental diet in the treatment of patients with Crohn's disease: the effects on protein metabolism and immune function","volume":"13","author":"O'Keefe","year":"1989","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1203\/PDR.0b013e31822f5886","article-title":"Corticosteroids increase protein breakdown and loss in newly diagnosed pediatric Crohn disease","volume":"70","author":"Steiner","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clnu.2023.03.021_bib24","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/ibd.20504","article-title":"Sarcopenia is prevalent in patients with Crohn's disease in clinical remission","volume":"14","author":"Schneider","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib25","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.clnu.2019.11.024","article-title":"Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review","volume":"39","author":"Donini","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib26","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.clnu.2018.04.018","article-title":"Sarcopenic obesity: time to meet the challenge","volume":"37","author":"Barazzoni","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/MIB.0000000000001128","article-title":"Sarcopenia is common in overweight patients with inflammatory bowel disease and may predict need for surgery","volume":"23","author":"Adams","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib28","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.clnu.2016.11.007","article-title":"Towards a multidisciplinary approach to understand and manage obesity and related diseases","volume":"36","author":"Bischoff","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000442721","article-title":"European guidelines for obesity management in adults","volume":"8","author":"Yumuk","year":"2015","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000490361","article-title":"Sarcopenic obesity: time to meet the challenge","volume":"11","author":"Barazzoni","year":"2018","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ibd\/izy212","article-title":"Sarcopenia and inflammatory bowel disease: a systematic review","volume":"25","author":"Ryan","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cgh.2019.11.009","article-title":"Management of inflammatory bowel diseases in special populations: obese, old, or obstetric","volume":"18","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","article-title":"Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes","volume":"14","author":"Singh","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcsm.12383","article-title":"GLIM criteria for the diagnosis of malnutrition - a consensus report from the global clinical nutrition community","volume":"10","author":"Cederholm","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2023.03.021_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.dld.2016.12.026","article-title":"Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFalpha therapy","volume":"49","author":"Emerenziani","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8646495","article-title":"Nutrition and IBD: malnutrition and\/or sarcopenia? A practical guide","volume":"2017","author":"Scaldaferri","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clnu.2023.03.021_bib38","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.clnu.2022.02.015","article-title":"ESPEN micronutrient guideline","volume":"41","author":"Berger","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib39","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/MPG.0b013e31828f1e86","article-title":"Micronutrient status in children with IBD: true deficiencies or epiphenomenon of the systemic inflammatory response","volume":"56","author":"Gerasimidis","year":"2013","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib40","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/MPG.0000000000000477","article-title":"Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease","volume":"59","author":"Santucci","year":"2014","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/jpepsy\/jst037","article-title":"Vitamin and mineral supplement adherence in pediatric inflammatory bowel disease","volume":"38","author":"Greenley","year":"2013","journal-title":"J\u00a0Pediatr Psychol"},{"key":"10.1016\/j.clnu.2023.03.021_bib42","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/nu10091192","article-title":"Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of myopenia and osteopenia","volume":"10","author":"Bryant","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.03.021_bib43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.crohns.2012.12.008","article-title":"Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients?","volume":"7","author":"Walldorf","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12328-019-01037-y","article-title":"Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms","volume":"13","author":"Szilagyi","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib45","first-page":"1","article-title":"Vitamin D and obesity in adults: a pathophysiological and clinical update","volume":"81","author":"Feghaly","year":"2020","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib46","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.12998\/wjcc.v7.i15.1908","article-title":"Bone alterations in inflammatory bowel diseases","volume":"7","author":"Sgambato","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.clnu.2023.03.021_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.17219\/acem\/78590","article-title":"Occurrence of dietary risk factors in inflammatory bowel disease: influence on the nutritional status of patients in clinical remission","volume":"28","author":"Pieczynska","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib48","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ecco-jcc\/jjx109","article-title":"Research gaps in diet and nutrition in inflammatory bowel disease. A topical review by D-ECCO working group [dietitians of ECCO]","volume":"11","author":"Sigall-Boneh","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/bjs.6805","article-title":"Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer","volume":"97","author":"Schwegler","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib50","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clnu.2008.03.012","article-title":"EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome","volume":"27","author":"Sorensen","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib51","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clnu.2018.05.024","article-title":"ESPEN guideline on clinical nutrition and hydration in geriatrics","volume":"38","author":"Volkert","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.nut.2008.03.018","article-title":"Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission","volume":"24","author":"Valentini","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.03.021_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2019.110607","article-title":"Phase angle as a severity indicator for liver diseases","volume":"70","author":"Pagano","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2023.03.021_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0148607115604149","article-title":"Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for clinicians using national institutes of health ImageJ","volume":"40","author":"Gomez-Perez","year":"2016","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jpen.1597","article-title":"Cancer-associated malnutrition and CT-defined sarcopenia and myosteatosis are endemic in overweight and obese patients","volume":"44","author":"Martin","year":"2020","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/clnu.2001.0503","article-title":"Crohn's disease clinical course and severity in obese patients","volume":"21","author":"Blain","year":"2002","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MEG.0b013e32835d1f15","article-title":"Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?","volume":"25","author":"Bhalme","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib58","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/ecco-jcc\/jjw079","article-title":"Relationship of body mass index to clinical outcomes after infliximab therapy in patients with crohn's disease","volume":"10","author":"Brown","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib59","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/MIB.0000000000001179","article-title":"Patients with crohn's disease with high body mass index present more frequent and rapid loss of response to infliximab","volume":"23","author":"Guerbau","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib60","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1097\/MIB.0b013e31829cf401","article-title":"Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease","volume":"19","author":"Harper","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib61","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/apt.14665","article-title":"High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis","volume":"47","author":"Kurnool","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00384-014-2051-3","article-title":"The effect of body weight on the severity and clinical course of ulcerative colitis","volume":"30","author":"Stabroth-Akil","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/codi.13128","article-title":"Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery","volume":"18","author":"Ding","year":"2016","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.05.005","article-title":"Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease","volume":"9","author":"Erhayiem","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/codi.12798","article-title":"Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease","volume":"17","author":"Li","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000496925","article-title":"Bariatric surgery is a safe and effective option for patients with inflammatory bowel diseases: a case series and systematic review of the literature","volume":"3","author":"Hudson","year":"2019","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib67","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.soard.2016.10.017","article-title":"Bariatric surgery in morbidly obese patients with inflammatory bowel disease: a systematic review","volume":"13","author":"Shoar","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/MOG.0000000000000422","article-title":"Obesity and inflammatory bowel disease: diagnostic and therapeutic implications","volume":"34","author":"Swanson","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib69","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.14293","article-title":"The body composition profile is associated with response to anti-TNF therapy in Crohn's disease and may offer an alternative dosing paradigm","volume":"46","author":"Ding","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib70","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04946.x","article-title":"Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients","volume":"35","author":"Bultman","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib71","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.3748\/wjg.v22.i35.7868","article-title":"Interaction of obesity and inflammatory bowel disease","volume":"22","author":"Harper","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib72","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib73","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","article-title":"GLP-1 induces barrier protective expression in Brunner's glands and regulates colonic inflammation","volume":"22","author":"Bang-Berthelsen","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib74","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3389\/fimmu.2017.01734","article-title":"Role of incretin Axis in inflammatory bowel disease","volume":"8","author":"Duan","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.clnu.2023.03.021_bib75","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jgh.13808","article-title":"Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats","volume":"33","author":"Nozu","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12967-018-1427-5","article-title":"Low dose Naltrexone for induction of remission in inflammatory bowel disease patients","volume":"16","author":"Lie","year":"2018","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib77","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/ecco-jcc\/jjy008","article-title":"The effect of low-dose Naltrexone on medication in inflammatory bowel disease: a quasi experimental before-and-after prescription database study","volume":"12","author":"Raknes","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib78","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s11695-017-3076-9","article-title":"Inflammatory bowel disease is not a contraindication for bariatric surgery","volume":"28","author":"Aelfers","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib79","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s11695-015-1909-y","article-title":"Outcomes of bariatric surgery in patients with inflammatory bowel disease","volume":"26","author":"Aminian","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ecco-jcc\/jju011","article-title":"Bariatric surgery in patients with inflammatory bowel disease: an accessible path? Report of a case series and review of the literature","volume":"9","author":"Colombo","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO guidelines on therapeutics in crohn's disease: surgical treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib82","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11695-017-2955-4","article-title":"Bariatric surgery is acceptably safe in obese inflammatory bowel disease patients: analysis of the nationwide inpatient sample","volume":"28","author":"Bazerbachi","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib83","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.soard.2016.01.022","article-title":"Fifth International Consensus Conference: current status of sleeve gastrectomy","volume":"12","author":"Gagner","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib84","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000449267","article-title":"Does gastric surgery (such as bariatric surgery) impact the risk of intestinal inflammation?","volume":"1","author":"Gero","year":"2016","journal-title":"Inflamm Intest Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib85","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/ibd.20373","article-title":"Ulcerative colitis exacerbating after placement of intragastric balloon for the treatment of obesity","volume":"14","author":"Manguso","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib86","doi-asserted-by":"crossref","first-page":"E539","DOI":"10.1152\/ajpendo.2000.279.3.E539","article-title":"Resting energy expenditure-fat-free mass relationship: new insights provided by body composition modeling","volume":"279","author":"Wang","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib87","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1203\/pdr.0b013e318030d11c","article-title":"Acute effects of enteral nutrition on protein turnover in adolescents with Crohn disease","volume":"61","author":"Hannon","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clnu.2023.03.021_bib88","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib89","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/gut.35.6.783","article-title":"Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome","volume":"35","author":"Royall","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2023.03.021_bib90","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/ibd.20102","article-title":"Protein and energy metabolism response to the initial dose of infliximab in children with Crohn's disease","volume":"13","author":"Steiner","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib91","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1258\/0007142991902204","article-title":"Manipulating the metabolic response to injury","volume":"55","author":"Griffiths","year":"1999","journal-title":"Br Med Bull"},{"key":"10.1016\/j.clnu.2023.03.021_bib92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/014860719501900295","article-title":"Total enteral nutrition support improves body composition of patients with active Crohn's disease","volume":"19","author":"Royall","year":"1995","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092163","article-title":"Effects of exercise and nutritional intervention on body composition, metabolic health, and physical performance in adults with sarcopenic obesity: a meta-analysis","volume":"11","author":"Hsu","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.03.021_bib94","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1053\/gast.2003.50106","article-title":"AGA technical review on osteoporosis in gastrointestinal diseases","volume":"124","author":"Bernstein","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/00365520600664276","article-title":"Skeletal morbidity in inflammatory bowel disease","author":"van Hogezand","year":"2006","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.clnu.2023.03.021_bib96","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjmed.2009.01.022","article-title":"Osteoporosis in inflammatory bowel disease","volume":"122","author":"Ali","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib97","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s10620-012-2531-7","article-title":"Vitamin d deficiency is associated with ulcerative colitis disease activity","volume":"58","author":"Blanck","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib98","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0016-5085(82)80135-2","article-title":"Vitamin D deficiency and bone disease in patients with Crohn's disease","volume":"83","author":"Driscoll","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib99","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2147\/TCRM.S3552","article-title":"The use of calcium and vitamin D in the management of osteoporosis","volume":"4","author":"Sunyecz","year":"2008","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.clnu.2023.03.021_bib100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.20452\/pamw.2981","article-title":"Calcium and phosphate metabolism in patients with inflammatory bowel diseases","volume":"125","author":"Krela-Ka\u017amierczak","year":"2015","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.puhe.2019.11.001","article-title":"Association of obesity with bone mineral density and osteoporosis in adults: a systematic review and meta-analysis","volume":"180","author":"Qiao","year":"2020","journal-title":"Publ Health"},{"key":"10.1016\/j.clnu.2023.03.021_bib102","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7150\/ijms.19213","article-title":"Systematic evaluation of corticosteroid use in obese and non-obese individuals: a multi-cohort study","volume":"14","author":"Savas","year":"2017","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib103","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10151-019-02080-0","article-title":"Outcomes of inflammatory bowel disease surgery in obese versus non-obese patients: a meta-analysis","volume":"23","author":"Hicks","year":"2019","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.clnu.2023.03.021_bib104","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/MIB.0000000000000335","article-title":"A\u00a0study evaluating the bidirectional relationship between inflammatory bowel disease and self-reported non-celiac gluten sensitivity","volume":"21","author":"Aziz","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib105","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/jhn.12018","article-title":"Nutritional inadequacies of the gluten-free diet in both recently-diagnosed and long-term patients with coeliac disease","volume":"26","author":"Shepherd","year":"2013","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.clnu.2023.03.021_bib106","first-page":"1510","article-title":"Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome","volume":"142","author":"Staudacher","year":"2012","journal-title":"J\u00a0Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2023.03.021_bib107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/jgh.13688","article-title":"Nutritional, microbiological and psychosocial implications of the low FODMAP diet","volume":"32","author":"Staudacher","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clnu.2016.09.004","article-title":"ESPEN guidelines on definitions and terminology of clinical nutrition","volume":"36","author":"Cederholm","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clnu.2004.08.012","article-title":"Increased length of hospital stay in underweight and overweight patients at hospital admission: a controlled population study","volume":"24","author":"Kyle","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib110","series-title":"Food and nutrients in disease management","article-title":"Irritable bowel syndrome","author":"Pickett-Blakely","year":"2009"},{"key":"10.1016\/j.clnu.2023.03.021_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ajg.2014.422","article-title":"Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome","volume":"110","author":"Lee","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib112","article-title":"A\u00a0conservative weight loss intervention relieves bowel symptoms in morbidly obese subjects with irritable bowel syndrome: a prospective cohort study","volume":"2018","author":"Aasbrenn","year":"2018","journal-title":"J\u00a0Obes"},{"key":"10.1016\/j.clnu.2023.03.021_bib113","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1381\/096089203322190835","article-title":"Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass","volume":"13","author":"Clements","year":"2003","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izaa097","article-title":"Multidimensional impact of mediterranean diet on IBD patients","volume":"27","author":"Chicco","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib115","first-page":"411","article-title":"Obesity and irritable bowel syndrome: a comprehensive review","volume":"10","author":"Pickett-Blakely","year":"2014","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib116","first-page":"740","article-title":"Tolerability of FODMAP - reduced diet in irritable bowel syndrome - efficacy, adherence, and body weight course","volume":"57","author":"Frieling","year":"2019","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib117","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11695-015-1907-0","article-title":"Increased prevalence of irritable bowel syndrome in a cohort of French morbidly obese patients candidate for bariatric surgery","volume":"26","author":"Schneck","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib118","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12876-019-1103-0","article-title":"Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study","volume":"19","author":"Blom-Hogestol","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib119","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fphar.2020.00332","article-title":"Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnu.2023.03.021_bib121","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijsu.2020.01.142","article-title":"The efficacy and safety of probiotics in patients with irritable bowel syndrome: evidence based on 35 randomized controlled trials","volume":"75","author":"Niu","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib122","first-page":"1323","volume":"59","author":"Layer","year":"2021","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib123","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/j.1365-2982.2008.01156.x","article-title":"A\u00a0mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome\u2013a randomized controlled trial with primary care physicians","volume":"20","author":"Enck","year":"2008","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.clnu.2023.03.021_bib124","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2036.2005.02579.x","article-title":"A\u00a0probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention","volume":"22","author":"Kajander","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib125","doi-asserted-by":"crossref","first-page":"10631","DOI":"10.3748\/wjg.v22.i48.10631","article-title":"Irritable bowel syndrome symptom severity improves equally with probiotic and placebo","volume":"22","author":"Lyra","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-230X-13-45","article-title":"A\u00a0randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome","volume":"13","author":"Roberts","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib127","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ctim.2019.01.010","article-title":"Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - what is the current evidence?","volume":"43","author":"Ooi","year":"2019","journal-title":"Compl Ther Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib128","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ajcn\/nqy376","article-title":"Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"109","author":"Wilson","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.15330","article-title":"Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome","volume":"50","author":"Ianiro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib130","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.14309\/ajg.0000000000000198","article-title":"Efficacy of fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis","volume":"114","author":"Xu","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib131","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/2050640619866990","article-title":"Fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis","volume":"7","author":"Myneedu","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.clnu.2023.03.021_bib132","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2023.03.021_bib133","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1007\/s11695-020-04607-z","article-title":"Celiac disease and obesity: is bariatric surgery an option?","volume":"30","author":"Lojou","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib134","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00394-016-1238-5","article-title":"Celiac disease: understanding the gluten-free diet","volume":"56","author":"Bascunan","year":"2017","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib135","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/nu12040940","article-title":"Celiac disease, gluten-free diet, and metabolic and liver disorders","volume":"12","author":"Valvano","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.03.021_bib136","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12664-016-0620-9","article-title":"Patients with celiac disease may have normal weight or may even be overweight","volume":"35","author":"Singh","year":"2016","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib137","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MCG.0b013e3181b7ed58","article-title":"Body mass index in celiac disease: beneficial effect of a gluten-free diet","volume":"44","author":"Cheng","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib138","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1089\/jmf.2014.0025","article-title":"Functional and metabolic disorders in celiac disease: new implications for nutritional treatment","volume":"17","author":"Farnetti","year":"2014","journal-title":"J\u00a0Med Food"},{"key":"10.1016\/j.clnu.2023.03.021_bib139","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1111\/j.1572-0241.2006.00750.x","article-title":"Overweight in celiac disease: prevalence, clinical characteristics, and effect of a gluten-free diet","volume":"101","author":"Dickey","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ejcn.2010.161","article-title":"Celiac disease and obesity: need for nutritional follow-up after diagnosis","volume":"64","author":"Valletta","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib141","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000369504","article-title":"Celiac disease and the gluten-free diet: consequences and recommendations for improvement","volume":"33","author":"Theethira","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib142","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gtc.2018.09.002","article-title":"Nutritional considerations of the gluten-free diet","volume":"48","author":"Dennis","year":"2019","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.clnu.2023.03.021_bib143","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/nu11010170","article-title":"Gluten-free diet: gaps and needs for a Healthier diet","volume":"11","author":"Melini","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2023.03.021_bib144","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ejcn.2015.114","article-title":"A\u00a0comparison of the nutritional status between adult celiac patients on a long-term, strictly gluten-free diet and healthy subjects","volume":"70","author":"Barone","year":"2016","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jacc.2010.09.073","article-title":"The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals","volume":"57","author":"Kastorini","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnu.2023.03.021_bib146","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/09637486.2016.1221900","article-title":"Adherence to the Mediterranean diet is inversely associated with metabolic syndrome occurrence: a meta-analysis of observational studies","volume":"68","author":"Godos","year":"2017","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib147","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3748\/wjg.v24.i19.2083","article-title":"Mediterranean diet and nonalcoholic fatty liver disease","volume":"24","author":"Anania","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib148","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MOG.0000000000000337","article-title":"Diet and gastroesophageal reflux disease: role in pathogenesis and management","volume":"33","author":"Sethi","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib149","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s11605-009-0930-7","article-title":"Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms","volume":"13","author":"Ayazi","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib150","first-page":"126","article-title":"Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases","volume":"91","author":"Maev","year":"2019","journal-title":"Ter Arkh"},{"key":"10.1016\/j.clnu.2023.03.021_bib151","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.gtc.2013.11.009","article-title":"Obesity and GERD","volume":"43","author":"Chang","year":"2014","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.clnu.2023.03.021_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56702-6","article-title":"Association between skeletal muscle attenuation and gastroesophageal reflux disease: a health check-up cohort study","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2023.03.021_bib153","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1572-0241.2006.00849.x","article-title":"Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"101","author":"Corley","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib154","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","article-title":"Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications","volume":"143","author":"Hampel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib155","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.08.019","article-title":"Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women","volume":"139","author":"Nam","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib156","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/gut.2007.147090","article-title":"Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups","volume":"57","author":"Chung","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.clnu.2023.03.021_bib157","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.surg.2015.04.034","article-title":"Gastroesophageal reflux disease in the obese: pathophysiology and treatment","volume":"159","author":"Nadaleto","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.clnu.2023.03.021_bib158","article-title":"Weight loss and waist reduction is associated with improvement in gastroesophageal disease reflux symptoms: a longitudinal study of 15 295 subjects undergoing health checkups","volume":"29","author":"Park","year":"2017","journal-title":"Neuro Gastroenterol Motil"},{"key":"10.1016\/j.clnu.2023.03.021_bib159","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2036.2009.04146.x","article-title":"Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease","volume":"30","author":"De Groot","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib160","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.3748\/wjg.v18.i28.3710","article-title":"Physical activity, obesity and gastroesophageal reflux disease in the general population","volume":"18","author":"Djarv","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/dote.12319","article-title":"Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: a comparative study","volume":"29","author":"de Bortoli","year":"2016","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.clnu.2023.03.021_bib162","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ajg.2012.466","article-title":"Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study","volume":"108","author":"Ness-Jensen","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib163","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/oby.20279","article-title":"Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial","volume":"21","author":"Singh","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib164","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/archinte.166.9.965","article-title":"Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach","volume":"166","author":"Kaltenbach","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.04.176","article-title":"Lifestyle intervention in gastroesophageal reflux disease","volume":"14","author":"Ness-Jensen","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib166","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/SLA.0000000000001139","article-title":"The impact of gastric bypass on gastroesophageal reflux disease in morbidly obese patients","volume":"263","author":"Madalosso","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib167","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijsu.2020.02.035","article-title":"Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a systematic review and meta-analysis based on 18 studies","volume":"76","author":"Han","year":"2020","journal-title":"Int J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib168","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3748\/wjg.v25.i6.729","article-title":"Body-mass index correlates with severity and mortality in acute pancreatitis: a meta-analysis","volume":"25","author":"Dobszai","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib169","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MOG.0000000000000386","article-title":"Obesity and pancreatitis","volume":"33","author":"Khatua","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib170","doi-asserted-by":"crossref","first-page":"m3109","DOI":"10.1136\/bmj.m3109","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2023.03.021_bib171","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cgh.2014.01.038","article-title":"Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies","volume":"12","author":"Alsamarrai","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib172","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0884533614528361","article-title":"The prevalence of malnutrition and fat-soluble vitamin deficiencies in chronic pancreatitis","volume":"29","author":"Duggan","year":"2014","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.03.021_bib173","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000490042","article-title":"Metabolic pancreatitis: pancreatic steatosis, hypertriglyceridemia, and associated chronic pancreatitis in 3 patients with metabolic syndrome","volume":"12","author":"Melitas","year":"2018","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib174","first-page":"365","article-title":"The burden of systemic adiposity on pancreatic disease: acute pancreatitis, non-alcoholic fatty pancreas disease, and pancreatic cancer","volume":"18","author":"Malli","year":"2017","journal-title":"JOP"},{"key":"10.1016\/j.clnu.2023.03.021_bib175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MPA.0000000000001252","article-title":"Association of pancreatic steatosis with chronic pancreatitis, obesity, and type 2 diabetes mellitus","volume":"48","author":"Tirkes","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.clnu.2023.03.021_bib176","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ajg.2017.181","article-title":"Patient and disease characteristics associated with the presence of diabetes mellitus in adults with chronic pancreatitis in the United States","volume":"112","author":"Bellin","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib177","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1001\/jama.2019.19411","article-title":"Diagnosis and management of chronic pancreatitis: a review","volume":"322","author":"Singh","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2023.03.021_bib178","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/CEG.S168266","article-title":"Exocrine pancreatic insufficiency: prevalence, diagnosis, and management","volume":"12","author":"Capurso","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib179","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000073655","article-title":"High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients","volume":"3","author":"Hardt","year":"2003","journal-title":"Pancreatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2318-11-4","article-title":"Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus","volume":"11","author":"Herzig","year":"2011","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clnu.2023.03.021_bib181","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.3748\/wjg.v19.i44.7930","article-title":"Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas","volume":"19","author":"Pezzilli","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib182","first-page":"158","article-title":"Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy?","volume":"11","author":"Dom\u00ednguez-Mu\u00f1oz","year":"2010","journal-title":"JOP J Pancreas"},{"key":"10.1016\/j.clnu.2023.03.021_bib183","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/jcsm.12039","article-title":"Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis","volume":"7","author":"Montano-Loza","year":"2016","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2023.03.021_bib184","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3390\/cells11081345","article-title":"Skeletal muscle pathological fat infiltration (myosteatosis) is associated with higher mortality in patients with cirrhosis","volume":"11","author":"Ebadi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clnu.2023.03.021_bib185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib186","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1017\/S0007114519002277","article-title":"Evaluation of the effectiveness of eight screening tools in detecting risk of malnutrition in cirrhotic patients: the KIRRHOS study","volume":"122","author":"Georgiou","year":"2019","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib187","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10620-015-4015-z","article-title":"The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis","volume":"61","author":"Borhofen","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib188","doi-asserted-by":"crossref","first-page":"i4428","DOI":"10.1136\/bmj.i4428","article-title":"Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2023.03.021_bib189","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib190","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib191","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib192","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.510230516","article-title":"Does malnutrition affect survival in cirrhosis? PINC (policentrica italiana nutrizione cirrosi)","volume":"23","author":"Merli","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib193","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3748\/wjg.14.1415","article-title":"Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound","volume":"14","author":"de Moura Almeida","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib194","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1381\/096089204323093408","article-title":"The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients","volume":"14","author":"Mottin","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib195","article-title":"Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49)","year":"2016","journal-title":"National Institute for Health and Clinical Excellence (NICE), London"},{"key":"10.1016\/j.clnu.2023.03.021_bib196","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib197","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"Electronic address eee, Clinical Practice Guideline P, Chair, representative EGB, Panel m. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib198","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"19","author":"Pu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib199","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2893.2012.01646.x","article-title":"Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B","volume":"20","author":"Friedrich-Rust","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.clnu.2023.03.021_bib200","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jgh.12557","article-title":"Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease","volume":"29","author":"Chan","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091987","article-title":"Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy","volume":"9","author":"Karlas","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.03.021_bib202","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jgh.13219","article-title":"Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease","volume":"31","author":"de Ledinghen","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2050640616646528","article-title":"Controlled attenuation parameter using the FibroScan\u00ae XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population","volume":"5","author":"Chan","year":"2017","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.clnu.2023.03.021_bib204","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28843","article-title":"Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values","volume":"65","author":"Petta","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib205","article-title":"Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.03.021_bib206","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1007\/s00330-019-06071-5","article-title":"Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis","volume":"29","author":"Qu","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clnu.2023.03.021_bib207","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address eee, European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib208","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jhep.2017.10.006","article-title":"Should we undertake surveillance for HCC in patients with NAFLD?","volume":"68","author":"Younes","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib209","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib210","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib211","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2019.04.019","article-title":"Anstee QM, participants of the AEW. Report on the AASLD\/EASL joint workshop on clinical trial endpoints in NAFLD","volume":"71","author":"Rinella","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib212","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib213","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib214","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib215","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.28992","article-title":"Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study","volume":"65","author":"Berzigotti","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib216","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/cld.722","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"11","author":"Chalasani","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib217","doi-asserted-by":"crossref","first-page":"O1","DOI":"10.1002\/oby.22719","volume":"28","author":"Mechanick","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib218","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib219","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/oby.21890","article-title":"Differential impact of weight loss on nonalcoholic fatty liver resolution in a north American cohort with obesity","volume":"25","author":"Rachakonda","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/obr.12776","article-title":"Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?","volume":"20","author":"De Fre","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib221","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.clnu.2019.04.023","article-title":"Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease","volume":"39","author":"Gan","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib222","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study","volume":"59","author":"Hong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib223","first-page":"185","article-title":"Sarcopenic obesity in fatty liver","volume":"22","author":"Merli","year":"2019","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2023.03.021_bib224","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3748\/wjg.v24.i30.3330","article-title":"Nutritional issues in patients with obesity and cirrhosis","volume":"24","author":"Schiavo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib225","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4254\/wjh.v9.i6.326","article-title":"Sarcopenia and non-alcoholic fatty liver disease: is there a relationship? A systematic review","volume":"9","author":"Tovo","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib226","article-title":"Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.03.021_bib227","series-title":"Non-alcoholic fatty liver disease: assessment and management","year":"2016"},{"key":"10.1016\/j.clnu.2023.03.021_bib228","first-page":"76","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations","volume":"8","author":"Kumar","year":"2020","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib229","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jceh.2019.07.008","article-title":"Extra-hepatic manifestations of nonalcoholic fatty liver disease: a review","volume":"10","author":"Tariq","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib230","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183415","article-title":"NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome","volume":"16","author":"Rosato","year":"2019","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.clnu.2023.03.021_bib231","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2015.01.027","article-title":"Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis","volume":"13","author":"Arulanandan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib233","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/MEG.0000000000001075","article-title":"Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis","volume":"30","author":"Zhou","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib234","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib235","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.23135","article-title":"Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels","volume":"50","author":"Haring","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib236","first-page":"153","article-title":"Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study","volume":"13","author":"Zhou","year":"2012","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib237","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2016.01.070","article-title":"Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis","volume":"67","author":"Zeb","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnu.2023.03.021_bib238","first-page":"2101","article-title":"Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study","volume":"50","author":"Jepsen","year":"2003","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib239","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib240","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib241","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib242","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib243","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S0007114519003064","article-title":"Dietary protein insufficiency: an important consideration in fatty liver disease?","volume":"123","author":"Ampong","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib244","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.10.007","article-title":"Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes","volume":"152","author":"Markova","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib245","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00125-019-4956-4","article-title":"A\u00a0carbohydrate-reduced high-protein diet improves HbA1c and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial","volume":"62","author":"Skytte","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.03.021_bib246","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clnu.2017.06.025","article-title":"ESPEN guidelines on nutritional support for polymorbid internal medicine patients","volume":"37","author":"Gomes","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib247","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3945\/ajcn.112.044321","article-title":"Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials","volume":"96","author":"Wycherley","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib248","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CIA.S96017","article-title":"Dietary protein intake in sarcopenic obese older women","volume":"11","author":"Muscariello","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.clnu.2023.03.021_bib249","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000468153","article-title":"Evaluation of hypocaloric diet with protein supplementation in middle-aged sarcopenic obese women: a pilot study","volume":"10","author":"Sammarco","year":"2017","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib250","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.24418","article-title":"Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis","volume":"54","author":"Berzigotti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib251","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/j.gastro.2009.05.007","article-title":"Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial","volume":"137","author":"Everhart","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib252","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/ajcn\/85.5.1257","article-title":"Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study","volume":"85","author":"Peng","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib253","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.510280526","article-title":"Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion","volume":"28","author":"McCullough","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib254","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1152\/ajpendo.00333.2001","article-title":"Impairment of albumin and whole body postprandial protein synthesis in compensated liver cirrhosis","volume":"282","author":"Tessari","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib255","first-page":"E140","article-title":"Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis","volume":"267","author":"Tessari","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.clnu.2023.03.021_bib256","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/hep.27717","article-title":"Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis","volume":"61","author":"Tsien","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib257","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1079\/BJN19950158","article-title":"Long-term oral refeeding of patients with cirrhosis of the liver","volume":"74","author":"Nielsen","year":"1995","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib258","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.299.6709.1202","article-title":"Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver","volume":"299","author":"Swart","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.clnu.2023.03.021_bib259","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1079\/BJN19940097","article-title":"One-month regular oral nutrition in alcoholic cirrhotic patients. Changes of nutritional status, hepatic function and serum lipid pattern","volume":"72","author":"Bories","year":"1994","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib260","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.clnu.2005.02.010","article-title":"Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: a prospective study","volume":"24","author":"Manguso","year":"2005","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib261","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnu.2007.08.011","article-title":"Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease\u2013a randomized controlled trial","volume":"27","author":"Norman","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib262","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.22367","article-title":"Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial","volume":"48","author":"Plank","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib263","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.38","article-title":"Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial","volume":"7","author":"Macias-Rodriguez","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib264","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.04.016","article-title":"Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis","volume":"12","author":"Zenith","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib265","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2036.2009.04230.x","article-title":"Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease","volume":"31","author":"Masterton","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnu.2023.03.021_bib266","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clnu.2017.01.003","article-title":"Fatty acid and non-alcoholic fatty liver disease: meta-analyses of case-control and randomized controlled trials","volume":"37","author":"Guo","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib267","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/nutrit\/nuy022","article-title":"Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease","volume":"76","author":"Musa-Veloso","year":"2018","journal-title":"Nutr Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib268","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012271","article-title":"Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"97","author":"Yan","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.clnu.2023.03.021_bib269","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.046","article-title":"No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial","volume":"147","author":"Sanyal","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib270","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.27289","article-title":"Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome\u2217 study","volume":"60","author":"Scorletti","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib271","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/nutrit\/nuy031","article-title":"Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"76","author":"Loman","year":"2018","journal-title":"Nutr Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib272","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ajcn\/nqz042","article-title":"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"110","author":"Sharpton","year":"2019","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib273","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MEG.0000000000001371","article-title":"The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis","volume":"31","author":"Khan","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib274","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s10620-019-05699-z","article-title":"Efficacy of probiotics and synbiotics in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"64","author":"Liu","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib275","first-page":"1090","article-title":"Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial","volume":"15","author":"Aller","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib276","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1665-2681(19)31364-X","article-title":"Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study","volume":"12","author":"Wong","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib277","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnu.2023.03.021_bib278","series-title":"UPDATE: potential risks with liquid-filled intragastric balloons - letter to health care providers","year":"2020"},{"key":"10.1016\/j.clnu.2023.03.021_bib279","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.clnu.2018.07.027","article-title":"Willing to go the extra mile: prospective evaluation of an intensified non-surgical treatment for patients with morbid obesity","volume":"38","author":"Weimann","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib280","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11695-020-05084-0","article-title":"Efficacy and safety of intragastric balloon (IGB) in non-alcoholic fatty liver disease (NAFLD): a comprehensive review and meta-analysis","volume":"31","author":"Chandan","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib281","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2023.03.021_bib282","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Frossing","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnu.2023.03.021_bib283","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00125-016-4100-7","article-title":"Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial","volume":"59","author":"Smits","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.03.021_bib284","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-019-05021-6","article-title":"Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation","volume":"63","author":"Bizino","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.03.021_bib285","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/liv.14065","article-title":"Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease","volume":"39","author":"Khoo","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.clnu.2023.03.021_bib286","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2023.03.021_bib287","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib288","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A\u00a0placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib289","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4239\/wjd.v10.i2.114","article-title":"SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: a systematic review","volume":"10","author":"Raj","year":"2019","journal-title":"World J Diabetes"},{"key":"10.1016\/j.clnu.2023.03.021_bib290","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jgh.15202","article-title":"The impact of sodium glucose co-transporter 2 inhibitors on non-alcoholic fatty liver disease","volume":"36","author":"Chrysavgis","year":"2021","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib291","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166125","article-title":"Benefits and harms of sodium-glucose Co-transporter 2 inhibitors in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"11","author":"Storgaard","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.03.021_bib292","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Milic","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib293","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cld.2015.10.008","article-title":"Effect of weight loss, diet, exercise, and bariatric surgery on nonalcoholic fatty liver disease","volume":"20","author":"Hannah","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib294","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.amjsurg.2019.09.006","article-title":"Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis","volume":"219","author":"Kwak","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib295","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/SLA.0000000000002397","article-title":"Liver function in patients with nonalcoholic fatty liver disease randomized to roux-en-Y gastric bypass versus sleeve gastrectomy: a secondary analysis of a randomized clinical trial","volume":"266","author":"Kalinowski","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib296","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.amjsurg.2019.07.027","article-title":"Roux-en-Y gastric bypass is a safe and effective option that improves major Co-Morbidities associated with obesity in an older, veteran population","volume":"218","author":"Lyo","year":"2019","journal-title":"Am J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib297","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.soard.2015.04.004","article-title":"Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study","volume":"12","author":"Froylich","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib298","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.soard.2018.07.012","article-title":"Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score)","volume":"14","author":"von Schonfels","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib299","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.soard.2019.09.060","article-title":"Systematic review and meta-analysis of Roux-en-Y gastric bypass against laparoscopic sleeve gastrectomy for amelioration of NAFLD using four criteria","volume":"15","author":"Baldwin","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2018.10.017","article-title":"Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0039-1697616","article-title":"Peculiarities of cirrhosis due to nonalcoholic steatohepatitis (NASH)","volume":"40","author":"El-Sherif","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib302","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000002433","article-title":"International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation","volume":"103","author":"Tsochatzis","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.clnu.2023.03.021_bib303","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011518","article-title":"Liver transplantation (LT) for cryptogenic cirrhosis (CC) and nonalcoholic steatohepatitis (NASH) cirrhosis: data from the scientific registry of transplant recipients (SRTR): 1994 to 2016","volume":"97","author":"Golabi","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.clnu.2023.03.021_bib304","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib305","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/ajt.15784","article-title":"Obesity, transplantation, and bariatric surgery: an evolving solution for a growing epidemic","volume":"20","author":"Diwan","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clnu.2023.03.021_bib306","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s11695-007-9208-x","article-title":"Nutritional deficiencies after bariatric surgery","volume":"17","author":"Davies","year":"2007","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib307","first-page":"676","article-title":"[Nutritional deficiencies in candidates for bariatric surgery]","volume":"5","author":"Ammor","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.clnu.2023.03.021_bib308","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11695-010-0352-3","article-title":"Vitamin D deficiency before bariatric surgery: should supplement intake be routinely prescribed?","volume":"21","author":"Ducloux","year":"2011","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib309","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/ibd.22906","article-title":"Micronutrient deficiencies in inflammatory bowel disease: from A to zinc","volume":"18","author":"Hwang","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib310","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3748\/wjg.v22.i3.1045","article-title":"Advances in nutritional therapy in inflammatory bowel diseases: review","volume":"22","author":"Wedrychowicz","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2023.03.021_bib311","first-page":"S1","volume":"21","author":"Mechanick","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib312","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib313","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.crohns.2014.08.012","article-title":"European evidence based consensus on surgery for ulcerative colitis","volume":"9","author":"Oresland","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.clnu.2023.03.021_bib314","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s11695-015-1727-2","article-title":"A\u00a0systematic review of bariatric surgery in patients with liver cirrhosis","volume":"25","author":"Jan","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib315","series-title":"S3-Leitlinie: chirurgie der Adipositas und metabolischer Erkrankungen","year":"2018"},{"key":"10.1016\/j.clnu.2023.03.021_bib316","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000355480","article-title":"Interdisciplinary European Guidelines on metabolic and bariatric surgery","volume":"6","author":"Fried","year":"2013","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib317","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.soard.2016.12.006","article-title":"Stability of problematic eating behaviors and weight loss trajectories after bariatric surgery: a longitudinal observational study","volume":"13","author":"Conceicao","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib318","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4088\/JCP.08m04328blu","article-title":"Loss of control over eating predicts outcomes in bariatric surgery patients: a prospective, 24-month follow-up study","volume":"71","author":"White","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.clnu.2023.03.021_bib319","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1381\/0960892053268327","article-title":"Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding","volume":"15","author":"Busetto","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1098-108X(1997)21:4<385::AID-EAT12>3.0.CO;2-Y","article-title":"Eating disturbances and outcome of gastric bypass surgery: a pilot study","volume":"21","author":"Hsu","year":"1997","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.clnu.2023.03.021_bib321","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/obr.12907","article-title":"Is weight regain after bariatric surgery associated with psychiatric comorbidity? A systematic review and meta-analysis","volume":"20","author":"Mauro","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib322","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(09)70159-7","article-title":"Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial","volume":"10","author":"Sj\u00f6str\u00f6m","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2023.03.021_bib323","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SLA.0000000000002525","article-title":"Bariatric surgery and the risk of cancer in a large multisite cohort","volume":"269","author":"Schauer","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib324","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.soard.2012.10.002","article-title":"Esophagogastric cancer after bariatric surgery: systematic review of the literature","volume":"9","author":"Scozzari","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib325","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1007\/s00464-020-07555-y","article-title":"Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP","volume":"34","author":"Di Lorenzo","year":"2020","journal-title":"Surg Endosc"},{"key":"10.1016\/j.clnu.2023.03.021_bib326","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000477267","article-title":"Clinical challenges in upper gastrointestinal malignancies after bariatric surgery","volume":"35","author":"Tse","year":"2018","journal-title":"Dig Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib327","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2009-2128","article-title":"Endocrine and nutritional management of the post-bariatric surgery patient: an endocrine society clinical practice guideline","volume":"95","author":"Heber","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib328","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1001\/jama.288.22.2793","article-title":"Bariatric surgery and long-term control of morbid obesity","volume":"288","author":"Brolin","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2023.03.021_bib329","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/0115426503018002141","article-title":"Roux-en-Y gastric bypass: the dietitian's and patient's perspectives","volume":"18","author":"Bock","year":"2003","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.03.021_bib330","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.soard.2018.12.029","article-title":"Long-term micronutrient surveillance after gastric bypass surgery in an integrated healthcare system","volume":"15","author":"Fox","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib331","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000481825","article-title":"Practical recommendations of the obesity management task force of the European association for the study of obesity for the post-bariatric surgery medical management","volume":"10","author":"Busetto","year":"2017","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib332","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s13679-017-0271-x","article-title":"Nutritional and micronutrient care of bariatric surgery patients: current evidence update","volume":"6","author":"Via","year":"2017","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.clnu.2023.03.021_bib333","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197248","article-title":"Predictive score of sarcopenia occurrence one year after bariatric surgery in severely obese patients","volume":"13","author":"Voican","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2023.03.021_bib334","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11695-013-1079-8","volume":"24","author":"Fried","year":"2014","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib335","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023208","article-title":"Effect of physical exercise on weight loss and physical function following bariatric surgery: a meta-analysis of randomised controlled trials","volume":"8","author":"Ren","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.clnu.2023.03.021_bib336","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s11695-015-1853-x","article-title":"Can composite nutritional supplement based on the current guidelines prevent vitamin and mineral deficiency after weight loss surgery?","volume":"26","author":"Boyce","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib337","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/bjs.10557","article-title":"Long-term follow-up after bariatric surgery in a national cohort","volume":"104","author":"Thereaux","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib338","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.soard.2008.08.009","volume":"4","author":"Mechanick","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib339","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0148607100024002126","article-title":"Managing the obese patient after bariatric surgery: a case report of severe malnutrition and review of the literature","volume":"24","author":"Kushner","year":"2000","journal-title":"J Parenter Enter Nutr"},{"key":"10.1016\/j.clnu.2023.03.021_bib340","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s002689900497","article-title":"Biliopancreatic diversion","volume":"22","author":"Scopinaro","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib341","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.soard.2015.10.084","article-title":"Exocrine pancreatic insufficiency after Roux-en-Y gastric bypass","volume":"12","author":"Borb\u00e9ly","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib342","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2019.01.021","article-title":"Short-term outcomes of inflammatory bowel disease after roux-en-Y gastric bypass vs sleeve gastrectomy","volume":"228","author":"Heshmati","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib343","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.soard.2014.06.022","article-title":"The role of bariatric surgery in morbidly obese patients with inflammatory bowel disease","volume":"11","author":"Keidar","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib344","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s11695-019-04267-8","article-title":"Is bariatric surgery safe and effective in patients with inflammatory bowel disease?","volume":"30","author":"McKenna","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib345","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s11695-017-2959-0","article-title":"Impact of bariatric surgery on outcomes of patients with inflammatory bowel disease: a nationwide inpatient sample analysis, 2004\u20132014","volume":"28","author":"Sharma","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib346","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40608-018-0206-4","article-title":"Changes in gastrointestinal symptoms and food tolerance 6 months following weight loss surgery: associations with dietary changes, weight loss and the surgical procedure","volume":"5","author":"Kvehaugen","year":"2018","journal-title":"BMC Obes"},{"key":"10.1016\/j.clnu.2023.03.021_bib347","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s11695-019-03737-3","article-title":"Quality of life and gastrointestinal symptoms following laparoscopic roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a systematic review","volume":"29","author":"Rausa","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib348","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1467-789X.2010.00731.x","article-title":"Physical activity and weight loss following bariatric surgery","volume":"12","author":"Jacobi","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib349","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/oby.21106","article-title":"Objective assessment of changes in physical activity and sedentary behavior: pre- through 3 years post-bariatric surgery","volume":"23","author":"King","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib350","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s11695-013-0979-y","article-title":"Moderate physical activity as predictor of weight loss after bariatric surgery","volume":"23","author":"Mundi","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib351","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/s41366-020-0585-8","article-title":"Physical activity impacts insulin sensitivity post metabolic bariatric surgery in adolescents with severe obesity","volume":"44","author":"Price","year":"2020","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnu.2023.03.021_bib352","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/oby.22475","article-title":"Physical activity improves lipid and weight-loss outcomes after metabolic bariatric surgery in adolescents with severe obesity","volume":"27","author":"Price","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib353","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.soard.2016.08.493","article-title":"Relationship among physical activity, sedentary behaviors, and cardiometabolic risk factors during gastric bypass surgery-induced weight loss","volume":"13","author":"Wefers","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib354","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cob.12256","article-title":"Effects of 6 months supervised physical training on muscle strength and aerobic capacity in patients undergoing Roux-en-Y gastric bypass surgery: a randomized controlled trial","volume":"8","author":"Mundbjerg","year":"2018","journal-title":"Clin Obes"},{"key":"10.1016\/j.clnu.2023.03.021_bib355","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/oby.22143","article-title":"Supervised physical training improves weight loss after roux-en-Y gastric bypass surgery: a randomized controlled trial","volume":"26","author":"Mundbjerg","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib356","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1007\/s11136-018-1938-9","article-title":"Physical training following gastric bypass: effects on physical activity and quality of life-a randomized controlled trial","volume":"27","author":"Stolberg","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.clnu.2023.03.021_bib357","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1007\/s11695-012-0739-4","article-title":"Do postoperative psychotherapeutic interventions and support groups influence weight loss following bariatric surgery? A systematic review and meta-analysis of randomized and nonrandomized trials","volume":"22","author":"Beck","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib358","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/obr.12013","article-title":"Post-operative behavioural management in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Rudolph","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib359","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s11695-015-1873-6","article-title":"Behavioural interventions for severe obesity before and\/or after bariatric surgery: a systematic review and meta-analysis","volume":"26","author":"Stewart","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib360","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/oby.20396","article-title":"The efficacy of a daily self-weighing weight loss intervention using smart scales and e-mail","volume":"21","author":"Steinberg","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib361","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.amepre.2013.08.006","article-title":"Daily self-weighing and adverse psychological outcomes: a randomized controlled trial","volume":"46","author":"Steinberg","year":"2014","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib362","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jhn.12492","article-title":"Nutritional monitoring of patients post-bariatric surgery: implications for smartphone applications","volume":"31","author":"Elvin-Walsh","year":"2018","journal-title":"J\u00a0Hum Nutr Diet"},{"key":"10.1016\/j.clnu.2023.03.021_bib363","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11695-016-2322-x","article-title":"A\u00a0pilot study on telephone cognitive behavioral therapy for patients six-months post-bariatric surgery","volume":"27","author":"Sockalingam","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib364","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1001\/jamainternmed.2013.1221","article-title":"Integrating technology into standard weight loss treatment: a randomized controlled trial","volume":"173","author":"Spring","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib365","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/oby.21842","article-title":"Effects of an abbreviated obesity intervention supported by mobile technology: the ENGAGED randomized clinical trial","volume":"25","author":"Spring","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib366","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/oby.21226","article-title":"Cell phone intervention for you (CITY): a randomized, controlled trial of behavioral weight loss intervention for young adults using mobile technology","volume":"23","author":"Svetkey","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib367","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/oby.21889","article-title":"The dietary intervention to enhance tracking with mobile devices (DIET mobile) study: a 6-month randomized weight loss trial","volume":"25","author":"Turner-McGrievy","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib368","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.orcp.2016.01.001","article-title":"High or low intensity text-messaging combined with group treatment equally promote weight loss maintenance in obese adults","volume":"10","author":"Zwickert","year":"2016","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/j.clnu.2023.03.021_bib369","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.03.021_bib370","first-page":"S5","volume":"22","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib371","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1001\/jama.2016.7602","article-title":"Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis","volume":"315","author":"Khera","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2023.03.021_bib372","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.2013.281361","article-title":"Long-term drug treatment for obesity: a systematic and clinical review","volume":"311","author":"Yanovski","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clnu.2023.03.021_bib373","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1590\/S0100-69912013000300005","article-title":"Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery","volume":"40","author":"Pajecki","year":"2013","journal-title":"Rev Col Bras Cir"},{"key":"10.1016\/j.clnu.2023.03.021_bib374","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1381\/096089296765556476","article-title":"Adjunctive use of appetite suppressant medications for improved weight management in bariatric surgical patients","volume":"6","author":"Jester","year":"1996","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib375","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11695-015-1979-x","article-title":"Pharmacotherapy in conjunction with a diet and exercise program for the treatment of weight recidivism or weight loss plateau post-bariatric surgery: a retrospective review","volume":"26","author":"Schwartz","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib376","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.soard.2016.10.018","article-title":"The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study","volume":"13","author":"Stanford","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib377","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1381\/0960892041590926","article-title":"Topiramate after adjustable gastric banding in patients with binge eating and difficulty losing weight","volume":"14","author":"Zilberstein","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib378","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s11695-019-03760-4","article-title":"Incidence and risk factors for cholelithiasis after bariatric surgery","volume":"29","author":"Guzman","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib379","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11695-014-1529-y","article-title":"Incidence of gallstone formation and cholecystectomy 10 Years after bariatric surgery","volume":"25","author":"Melmer","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib380","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/sjg.SJG_472_19","article-title":"Incidence of symptomatic cholelithiasis after laparoscopic sleeve gastrectomy and its association with rapid weight loss","volume":"26","author":"Alsaif","year":"2020","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib381","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s00464-009-0422-6","article-title":"Symptomatic gallstones after sleeve gastrectomy","volume":"23","author":"Li","year":"2009","journal-title":"Surg Endosc"},{"key":"10.1016\/j.clnu.2023.03.021_bib382","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s11695-019-04366-6","article-title":"Increased incidence of symptomatic cholelithiasis after bariatric roux-en-Y gastric bypass and previous bariatric surgery: a single center experience","volume":"30","author":"Sneineh","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib383","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhep.2016.03.005","article-title":"Electronic address eee. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones","volume":"65","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib384","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s11695-017-2924-y","article-title":"Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: an updated systematic review and meta-analysis","volume":"27","author":"Magouliotis","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib385","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12876-017-0674-x","article-title":"Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)","volume":"17","author":"Boerlage","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnu.2023.03.021_bib386","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1007\/s11695-018-3443-1","article-title":"Cholecystectomy in patients submitted to bariatric procedure: a systematic review and meta-analysis","volume":"28","author":"Tustumi","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib387","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib388","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MEG.0000000000001300","article-title":"The association between obesity and outcomes in acute pancreatitis: an individual patient data meta-analysis","volume":"31","author":"Smeets","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clnu.2023.03.021_bib389","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMra1505202","article-title":"Acute pancreatitis","volume":"375","author":"Forsmark","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib390","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.pan.2013.07.063","article-title":"IAP\/APA evidence-based guidelines for the management of acute pancreatitis","volume":"13","year":"2013","journal-title":"Pancreatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib391","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000077021","article-title":"Combination of Apache-II score and an obesity score (Apache-O) for the prediction of severe acute pancreatitis","volume":"4","author":"Johnson","year":"2004","journal-title":"Pancreatology"},{"key":"10.1016\/j.clnu.2023.03.021_bib392","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1007\/s11695-018-3446-y","article-title":"The effects of laparoscopic sleeve gastrectomy on obesity-related hypertriglyceridemia-induced acute pancreatitis","volume":"28","author":"Song","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib393","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/EJE-16-1062","article-title":"Management of endocrine disease: pathogenesis and management of hypoglycemia","volume":"177","author":"Kittah","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clnu.2023.03.021_bib394","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/oby.21520","article-title":"How common is hypoglycemia after gastric bypass?","volume":"24","author":"Goldfine","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib395","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-010-1798-5","article-title":"Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden","volume":"53","author":"Marsk","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.03.021_bib396","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.soard.2018.01.028","article-title":"The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery","volume":"14","author":"Lee","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib397","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.soard.2014.11.003","article-title":"Hypoglycemia after Roux-En-Y gastric bypass: detection rates of continuous glucose monitoring (CGM) versus mixed meal test","volume":"11","author":"Kefurt","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib398","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/clinem\/dgab323","article-title":"Glycemic patterns are distinct in post-bariatric hypoglycemia after gastric bypass (PBH-RYGB)","volume":"106","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib399","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1007\/s00125-013-3003-0","article-title":"Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals","volume":"56","author":"Jacobsen","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.03.021_bib400","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/oby.20791","article-title":"Rapid gastric and intestinal transit is a major determinant of changes in blood glucose, intestinal hormones, glucose absorption and postprandial symptoms after gastric bypass","volume":"22","author":"Nguyen","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.clnu.2023.03.021_bib401","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db11-0203","article-title":"Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans","volume":"60","author":"Salehi","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2023.03.021_bib402","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1530\/EJE-17-0446","article-title":"Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass","volume":"177","author":"Tharakan","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clnu.2023.03.021_bib403","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.2337\/db13-0321","article-title":"Long-term effects of bariatric surgery on meal disposal and beta-cell function in diabetic and nondiabetic patients","volume":"62","author":"Camastra","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.clnu.2023.03.021_bib404","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00125-010-1901-y","article-title":"Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass","volume":"53","author":"Reubi","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnu.2023.03.021_bib405","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2013.11.044","article-title":"Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass","volume":"146","author":"Salehi","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnu.2023.03.021_bib406","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s11695-020-04465-9","article-title":"Impact of postprandial hypoglycemia on weight loss after bariatric surgery","volume":"30","author":"Rebelos","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib407","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s11695-018-03699-y","article-title":"Prevalence of dumping syndrome after laparoscopic sleeve gastrectomy and comparison with laparoscopic roux-en-Y gastric bypass","volume":"29","author":"Ahmad","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.clnu.2023.03.021_bib408","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2337\/dc06-2556","article-title":"An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes","volume":"30","author":"Geddes","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clnu.2023.03.021_bib409","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2017-01695","article-title":"Incidence of hypoglycemia after gastric bypass vs sleeve gastrectomy: a randomized trial","volume":"103","author":"Capristo","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib410","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.soard.2020.04.024","article-title":"Relationship between biochemical and symptomatic hypoglycemia after RYGB. Responses to a mixed meal test: a case-control study","volume":"16","author":"Soeby","year":"2020","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib411","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.numecd.2020.06.029","article-title":"Continuous glucose monitoring in subjects undergoing bariatric surgery: diurnal and nocturnal glycemic patterns","volume":"30","author":"Lupoli","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib412","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/obr.12307","article-title":"Diagnostic tools for post-gastric bypass hypoglycaemia","volume":"16","author":"Emous","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib413","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.soard.2017.01.025","article-title":"Medical nutrition therapy for post-bariatric hypoglycemia: practical insights","volume":"13","author":"Suhl","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib414","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/dom.13796","article-title":"Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide","volume":"21","author":"Ohrstrom","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.clnu.2023.03.021_bib415","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/obr.12467","article-title":"Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management","volume":"18","author":"van Beek","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2023.03.021_bib416","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000515598","article-title":"Canagliflozin: a new therapeutic option in patients that present postprandial hyperinsulinemic hypoglycemia after roux-en-Y gastric bypass: a pilot study","volume":"14","author":"Ciudin","year":"2021","journal-title":"Obes Facts"},{"key":"10.1016\/j.clnu.2023.03.021_bib417","doi-asserted-by":"crossref","first-page":"e3235","DOI":"10.1210\/clinem\/dgab103","article-title":"PREVENT: a randomized, placebo-controlled crossover trial of avexitide for treatment of postbariatric hypoglycemia","volume":"106","author":"Craig","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib418","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1210\/clinem\/dgz197","article-title":"A\u00a0randomized, placebo-controlled double-blind trial of a closed-loop glucagon system for postbariatric hypoglycemia","volume":"105","author":"Mulla","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.clnu.2023.03.021_bib419","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.giec.2016.12.007","article-title":"Endoscopic treatments following bariatric surgery","volume":"27","author":"Storm","year":"2017","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.clnu.2023.03.021_bib420","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cob.12182","article-title":"Review article including treatment algorithm: endoscopic treatment of luminal complications after bariatric surgery","volume":"7","author":"Valli","year":"2017","journal-title":"Clin Obes"},{"key":"10.1016\/j.clnu.2023.03.021_bib421","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.soard.2013.05.012","article-title":"Laparoscopic reversal of Roux-en-Y gastric bypass: technique and utility for treatment of endocrine complications","volume":"10","author":"Campos","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib422","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.soard.2019.05.005","article-title":"Reversal of Roux en Y gastric bypass: largest single institution experience","volume":"15","author":"Ma","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib423","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.soard.2016.12.005","article-title":"ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery","volume":"13","author":"Eisenberg","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.clnu.2023.03.021_bib424","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/003335491012500402","article-title":"The Surgeon General's vision for a healthy and fit nation","volume":"125","author":"Benjamin","year":"2010","journal-title":"Publ Health Rep"},{"key":"10.1016\/j.clnu.2023.03.021_bib425","series-title":"London: national Institute for health and care excellence (NICE); 2015 mar. (NICE clinical guidelines, No. 43.)","year":"2015"},{"key":"10.1016\/j.clnu.2023.03.021_bib426","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1161\/01.CIR.0000145546.97738.1E","volume":"110","author":"Klein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clnu.2023.03.021_bib427","series-title":"Assessment and management of adult obesity: a primer for physicians","year":"2003"},{"key":"10.1016\/j.clnu.2023.03.021_bib428","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7326\/0003-4819-139-11-200312020-00013","article-title":"Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force","volume":"139","author":"McTigue","year":"2003","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2023.03.021_bib429","first-page":"51S","article-title":"National institutes of health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.clnu.2023.03.021_bib430","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1479-5868-10-40","article-title":"Effectiveness of a motivational interviewing intervention on weight loss, physical activity and cardiovascular disease risk factors: a randomised controlled trial with a 12-month post-intervention follow-up","volume":"10","author":"Hardcastle","year":"2013","journal-title":"Int J Behav Nutr Phys Activ"},{"key":"10.1016\/j.clnu.2023.03.021_bib431","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1370\/afm.1615","article-title":"Shared decision making and motivational interviewing: achieving patient-centered care across the spectrum of health care problems","volume":"12","author":"Elwyn","year":"2014","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib432","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.acap.2018.05.004","article-title":"Obesity prevention and treatment in primary care","volume":"18","author":"Brown","year":"2018","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.clnu.2023.03.021_bib433","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archinternmed.2011.22","article-title":"Preventing weight gain by lifestyle intervention in a general practice setting: three-year results of a randomized controlled trial","volume":"171","author":"ter Bogt","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clnu.2023.03.021_bib434","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1503\/cmaj.061409","article-title":"2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]","volume":"176","author":"Lau","year":"2007","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.clnu.2023.03.021_bib435","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.pec.2017.07.032","article-title":"Does evidence support the use of mobile phone apps as a driver for promoting healthy lifestyles from a public health perspective? A systematic review of Randomized Control Trials","volume":"100","author":"Covolo","year":"2017","journal-title":"Patient Educ Counsel"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423001024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423001024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:13:47Z","timestamp":1759367627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":435,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0261561423001024"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.03.021","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical guideline on obesity care in patients with gastrointestinal and liver diseases \u2013 Joint ESPEN\/UEG guideline","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}